UA113233U - ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT - Google Patents

ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT

Info

Publication number
UA113233U
UA113233U UAU201605787U UAU201605787U UA113233U UA 113233 U UA113233 U UA 113233U UA U201605787 U UAU201605787 U UA U201605787U UA U201605787 U UAU201605787 U UA U201605787U UA 113233 U UA113233 U UA 113233U
Authority
UA
Ukraine
Prior art keywords
component
tenoxicam
analyting
sodium
fixed combination
Prior art date
Application number
UAU201605787U
Other languages
Ukrainian (uk)
Inventor
Антон Миколайович Сікорський
Original Assignee
Антон Миколайович Сікорський
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Антон Миколайович Сікорський filed Critical Антон Миколайович Сікорський
Priority to UAU201605787U priority Critical patent/UA113233U/en
Publication of UA113233U publication Critical patent/UA113233U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтична композиція для перорального споживання є комбінацією щонайменше двох активних компонентів в їхніх ефективних кількостях, в тому числі у вигляді фармацевтично прийнятних солей, сольватів, естерів, оптичних ізомерів та прекурсорів, які вивільняються негайно, при цьому один з компонентів проявляє снодійний та/або заспокійливий ефект, а другий - знеболюючий ефект. Знеболювальним компонентом є теноксикам.A pharmaceutical composition for oral administration is a combination of at least two active ingredients in their effective amounts, including in the form of pharmaceutically acceptable salts, solvates, esters, optical isomers and precursors, which are released immediately, with one component exhibiting a drowsy and / or dormant effect and the second anesthetic effect. The anesthetic component is tenoxicam.

UAU201605787U 2016-05-30 2016-05-30 ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT UA113233U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201605787U UA113233U (en) 2016-05-30 2016-05-30 ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201605787U UA113233U (en) 2016-05-30 2016-05-30 ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT

Publications (1)

Publication Number Publication Date
UA113233U true UA113233U (en) 2017-01-25

Family

ID=58049700

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201605787U UA113233U (en) 2016-05-30 2016-05-30 ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT

Country Status (1)

Country Link
UA (1) UA113233U (en)

Similar Documents

Publication Publication Date Title
CO2020000145A2 (en) Carboxamides as sodium channel modulators
CO2019000945A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2019000943A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
DOP2016000156A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AZD9291.
BR112018073663A2 (en) Spiro-lactam nmda receptor modulators and their uses
CO2019000941A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2019000938A2 (en) Nmda spiro-lactam modulators and methods of use thereof
CO2019000944A2 (en) Modulators of the nmda spiro-lactam and bis-spiro-lactam receptor and use thereof
UY36422A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
MX2020007625A (en) Mtor inhibitor, pharmaceutical composition and use thereof.
BR112015018087A8 (en) compound, pharmaceutical composition and use
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
CL2021002107A1 (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria.
AR115913A1 (en) BIO AVAILABLE ORAL DOSAGE FORMS, USE, METHODS
BR112012030654A2 (en) bendamustine oral dosage forms
TR201821114A2 (en) EFERVESCENT PHARMACEUTICAL COMPOSITION WITH ERDOSTEIN
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
UA113233U (en) ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT
BR112017014295A2 (en) pharmaceutical composition.
UA113237U (en) PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
MX2021001349A (en) A new medical treatment for pathologic inflammation.
CO2018013792A2 (en) Dosing regimens of vortioxetine for the rapid onset of the antidepressant effect
UA113236U (en) PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam
AR099330A1 (en) USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA